Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Gliosarcoma 2Glioblastoma 2Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pinealoma 1Pancreatic Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Meningioma 1Medulloblastoma 1Liver Neoplasms 1Glioma, Subependymal 1Glioma 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Craniopharyngioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Choroid Plexus Neoplasms 1Chondrosarcoma, Mesenchymal 1Chondrosarcoma, Clear Cell 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bile Duct Neoplasms 1

Interventions

sargramostim 1indolepropanol phosphate 1Vincristine 1Tirapazamine 1Pharmacogenomic Testing 1Irinotecan 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Alveolar Childhood Rhabdomyosarcoma × Pharmacogenomic Testing × Sarcoma × Clear all
NCT00025363 2013-01-17

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
150 enrolled
Sarcoma

Alveolar Childhood Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡